3-D Matrix, Ltd. (DMTRF)

Market Cap	341.63M +176.2%
Revenue (ttm)	59.75M +38.4%
Net Income	8.07M
EPS	0.06
Shares Out	n/a
PE Ratio	42.31
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	36,545
Average Volume	4,930
Open	3.960
Previous Close	2.370
Day's Range	3.960 - 3.960
52-Week Range	1.500 - 3.960
Beta	0.52
RSI	61.55
Earnings Date	Jun 12, 2026

About 3-D Matrix

3-D Matrix, Ltd. developing, manufacturing, and selling self-assembling peptide technology in Japan and internationally. It offers PuraMatrix, a self-assembling peptide hydrogel for use in the regenerative medicine, cell therapy, drug delivery systems, and other uses in various fields. The company was incorporated in 2004 and is based in Tokyo, Japan

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 114
• Stock Exchange: OTCMKTS
• Ticker Symbol: DMTRF

Financial Performance

In fiscal year 2025, 3-D Matrix's revenue was 6.93 billion, an increase of 51.13% compared to the previous year's 4.59 billion. Losses were -2.50 billion, 880.8% more than in 2024.

Financial numbers in JPY